Literature DB >> 20636637

Cross-prevalence of migraine and bipolar disorder.

Abigail Ortiz1, Pablo Cervantes, Gregorio Zlotnik, Caroline van de Velde, Claire Slaney, Julie Garnham, Gustavo Turecki, Claire O'Donovan, Martin Alda.   

Abstract

OBJECTIVE: In two related studies, we explored the prevalence of migraine and its associated clinical characteristics in patients with bipolar disorder (BD) as well as psychiatric morbidity in patients treated for migraine.
METHOD: The first study included 323 subjects with BD type I (BD I) or BD type II (BD II), diagnosed using the Schedule for Affective Disorders and Schizophrenia, Lifetime version (SADS-L) format, or the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). Migraine history was assessed by means of a structured questionnaire. In a second sample of 102 migraine patients, we investigated current and lifetime psychiatric morbidity using the SADS-L. Statistical analyses were conducted using nonparametric analysis and log-linear models.
RESULTS: A total of 24.5% of BD patients had comorbid migraine; those with BD II had a higher prevalence (34.8%) compared to BD I (19.1%) (p < 0.005). BD patients with comorbid migraine had significantly higher rates of suicidal behaviour, social phobia, panic disorder, generalized anxiety disorder, and obsessive-compulsive disorder (all p < 0.05). In the sample of migraine patients, 34.3% had a current psychiatric diagnosis, and 73.5% had a lifetime psychiatric diagnosis. The prevalence of BD I was 4.9%, and 7.8% for BD II. DISCUSSION: Migraine is prevalent within the BD population, particularly among BD II subjects. It is associated with an increased risk of suicidal behaviour and comorbid anxiety disorders. Conversely, migraine sufferers have high rates of current and lifetime psychopathology. A greater understanding of this comorbidity may contribute to our knowledge of the underlying mechanisms of BD.

Entities:  

Mesh:

Year:  2010        PMID: 20636637     DOI: 10.1111/j.1399-5618.2010.00832.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  19 in total

1.  Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.

Authors:  Erika Fh Saunders; Aubrey Reider; Gagan Singh; Alan J Gelenberg; Stanley I Rapoport
Journal:  Bipolar Disord       Date:  2015-10-01       Impact factor: 6.744

Review 2.  White matter hyperintensities: from medical comorbidities to bipolar disorders and back.

Authors:  Eva Gunde; Ryan Blagdon; Tomas Hajek
Journal:  Ann Med       Date:  2011-07-13       Impact factor: 4.709

3.  Prevalence and comorbidity of migraine headache: results from the Singapore Mental Health Study 2016.

Authors:  Anitha Jeyagurunathan; Edimansyah Abdin; Janhavi Ajit Vaingankar; Boon Yiang Chua; Saleha Shafie; Shi Hui Sherilyn Chang; Lyn James; Kelvin Bryan Tan; Sutapa Basu; Siow Ann Chong; Mythily Subramaniam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-08-27       Impact factor: 4.328

4.  Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture.

Authors:  Erika F H Saunders; Christopher E Ramsden; Mostafa S Sherazy; Alan J Gelenberg; John M Davis; Stanley I Rapoport
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

5.  Gender differences, clinical correlates, and longitudinal outcome of bipolar disorder with comorbid migraine.

Authors:  Erika F H Saunders; Racha Nazir; Masoud Kamali; Kelly A Ryan; Simon Evans; Scott Langenecker; Alan J Gelenberg; Melvin G McInnis
Journal:  J Clin Psychiatry       Date:  2014-05       Impact factor: 4.384

6.  General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.

Authors:  D E Kemp; L G Sylvia; J R Calabrese; A A Nierenberg; M E Thase; N A Reilly-Harrington; M J Ostacher; A C Leon; T A Ketter; E S Friedman; C L Bowden; D J Rabideau; M Pencina; D V Iosifescu
Journal:  Acta Psychiatr Scand       Date:  2013-03-07       Impact factor: 6.392

7.  Concomitant medication of psychoses in a lifetime perspective.

Authors:  Maria Vares; Peter Saetre; Pontus Strålin; Sten Levander; Eva Lindström; Erik G Jönsson
Journal:  Hum Psychopharmacol       Date:  2011-06-22       Impact factor: 1.672

8.  Bipolar affective disorder and migraine.

Authors:  Birk Engmann
Journal:  Case Rep Med       Date:  2012-05-09

9.  Chronic Migraine Preventive Treatment by Prefrontal-Occipital Transcranial Direct Current Stimulation (tDCS): A Proof-of-Concept Study on the Effect of Psychiatric Comorbidities.

Authors:  Giulio Mastria; Alessandro Viganò; Alessandra Corrado; Valentina Mancini; Cristina Pirillo; Simone Badini; Barbara Petolicchio; Massimiliano Toscano; Marta Altieri; Roberto Delle Chiaie; Vittorio Di Piero
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

10.  Migraine: Clinical pattern and psychiatric comorbidity.

Authors:  Manjeet Singh Bhatia; Ravi Gupta
Journal:  Ind Psychiatry J       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.